PharmiWeb Recruiter Blog

Tübingen and Ingelheim, Germany, 20 October 2022 – University of Tübingen, a leading member of Cyber Valley, Europe’s largest Artificial Intelligence (AI) research consortium and Boehringer Ingelheim launch an AI and data science fellowship program for top talents from around the world. Three to five fellowships will be awarded per year for up to three years with a target of nine to fifteen fellows in the program after five years.

• Proposed acquisition will accelerate gene therapies that aim to restore, improve, and preserve hearing for patients living with disabling hearing loss worldwide
• Transaction valued at approximately $487 million plus a contingent value right for an aggregate amount up to approximately $610 million

INDIANAPOLIS and BOSTON, Oct. 18, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced a definitive agreement for Lilly to acquire Akouos, a precision genetic medicine company that is developing a portfolio of first-in-class adeno-associated viral gene therapies for the treatment of inner ear conditions, including sensorineural hearing loss.

• Collaboration leverages one of world’s largest sources of de-identified patient data to accelerate drug discovery, initially in oncology

• Access will enable GSK to...

• AMGEN TO JOIN LAB150 TO BUILD CANADA’S NEXT GENERATION OF LIFE SCIENCE COMPANIES

Hamburg, Germany, and Toronto, Canada, 17 October, 2022:Evotec SE (Frankfurt Stock...

Agreement key to building pan-European market access practice while underscoring a think global, act local commitment  

$97 million investment enhances bioanalytical services, helping pharma and biotech customers accelerate drug development

Collaboration Streamlines Clinical Trial Tokenization, Further Empowers Medical Affairs, Market Access, HEOR and Commercial Analytics for Clients  

Acquisition adds breakthrough calcitonin gene-related peptide portfolio, including NURTEC® ODT, to address needs of millions of migraine patients worldwide

BURLINGTON, N.C.--(BUSINESS WIRE)--Oct. 3, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the completion of transactions that establish a long-term laboratory relationship with Ascension, one of the leading non-profit and Catholic health systems in the United States.

London, 28 September 2022 — Novartis Pharmaceuticals UK has today announced that Xim, creators of Lifelight, and PocDoc are the successful companies of the Novartis Biome UK Heart Health Catalyst 2022, in partnership with Medtronic, RYSE Asset Management, Chelsea and Westminster Hospital NHS Foundation Trust and its official charity CW+.